Edition:
United States

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

1.05USD
23 May 2018
Change (% chg)

$0.09 (+9.90%)
Prev Close
$0.96
Open
$0.96
Day's High
$1.15
Day's Low
$0.95
Volume
84,800
Avg. Vol
95,981
52-wk High
$4.32
52-wk Low
$0.83

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.18 December 28 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 1 1 3 3
(3) HOLD 2 2 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.25 2.25 1.75 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 1 7.85 7.85 7.85 --
Quarter Ending Sep-18 1 8.12 8.12 8.12 --
Year Ending Dec-18 2 31.47 31.94 31.00 59.70
Year Ending Dec-19 2 47.03 47.24 46.82 --
Earnings (per share)
Quarter Ending Jun-18 1 -0.18 -0.18 -0.18 --
Quarter Ending Sep-18 1 -0.17 -0.17 -0.17 --
Year Ending Dec-18 2 -0.56 -0.43 -0.69 0.09
Year Ending Dec-19 2 -0.28 -0.22 -0.35 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 8.20 7.67 0.53 6.49
Quarter Ending Dec-17 9.19 7.52 1.67 18.16
Quarter Ending Sep-17 7.91 8.03 0.11 1.45
Quarter Ending Jun-17 7.97 6.60 1.36 17.10
Quarter Ending Mar-17 7.60 6.97 0.63 8.34
Earnings (per share)
Quarter Ending Mar-18 -0.13 -0.16 0.03 -23.08
Quarter Ending Dec-17 -0.11 -0.36 0.25 -227.27
Quarter Ending Sep-17 -0.12 -0.15 0.03 -21.65
Quarter Ending Jun-17 -0.15 -0.16 0.01 -6.67
Quarter Ending Mar-17 -0.18 -0.51 0.33 -183.33

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 7.85 7.85 8.84 9.89 --
Quarter Ending Sep-18 8.12 8.12 9.60 10.89 --
Year Ending Dec-18 31.47 31.47 34.21 41.23 59.70
Year Ending Dec-19 47.03 47.03 47.03 47.03 --
Earnings (per share)
Quarter Ending Jun-18 -0.18 -0.18 -0.13 -0.06 --
Quarter Ending Sep-18 -0.17 -0.17 -0.13 -0.03 --
Year Ending Dec-18 -0.56 -0.56 -0.47 -0.26 0.09
Year Ending Dec-19 -0.28 -0.28 -0.29 -0.20 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 1
Quarter Ending Sep-18 0 0 0 1
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Jun-18 0 0 0 1
Quarter Ending Sep-18 0 0 0 1
Year Ending Dec-18 0 0 0 1
Year Ending Dec-19 0 0 1 0